NCT06305598 2026-02-19Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate CancerRoswell Park Cancer InstitutePhase 1 Recruiting14 enrolled